NIH VideoCast - Anti-Aging Medicines: The Beginning of the End of the Beginning

Skip Navigation

Anti-Aging Medicines: The Beginning of the End of the Beginning

Loading... Loading video...

808 Views

Air date:	Tuesday, August 21, 2012, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 808 (69 Live, 739 On-demand)
Category:	Geroscience
Runtime:	00:59:41
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	The Geroscience Interest Group (GSIG) cordially invites you to the seminar presented by Dr. Richard Miller. Dr. Miller is a Professor of Pathology and Director of the Nathan Shock Center on Aging at the University of Michigan. He directs one of the three laboratories involved in the NIA-sponsored Interventions Testing Program (ITP) and in that capacity made a seminal contribution to the discovery that rapamycin increases lifespan in mice. His seminar will provide further research information on the ITP, rapamycin and other anti-aging interventions. He has a wide interest in biogerontology, with a special emphasis on the use of animal models to study mechanisms regulating longevity and stress resistance. The Geroscience Interest Group (GSIG) is a newly formed trans-NIH group aimed at enhancing opportunities for discussion of the intersection between the biology of aging and the biology of diseases and conditions that are of interest across ICs. It is focused on basic biology, but with a longer view towards translation. If you are interested in learning more, please visit the GSIG web site http://sigs.nih.gov/geroscience/Pages/default.aspx

NLM Title:	Anti-aging medicines : the beginning of the end of the beginning / Richard Miller ; Geroscience Interest Group.
Author:	Miller, Richard. National Institutes of Health (U.S.). Geroscience Interest Group.
Publisher:
Abstract:	(CIT): The Geroscience Interest Group (GSIG) cordially invites you to the seminar presented by Dr. Richard Miller. Dr. Miller is a Professor of Pathology and Director of the Nathan Shock Center on Aging at the University of Michigan. He directs one of the three laboratories involved in the NIA-sponsored Interventions Testing Program (ITP) and in that capacity made a seminal contribution to the discovery that rapamycin increases lifespan in mice. His seminar will provide further research information on the ITP, rapamycin and other anti-aging interventions. He has a wide interest in biogerontology, with a special emphasis on the use of animal models to study mechanisms regulating longevity and stress resistance.
Subjects:	Aging Chronic Disease--prevention & control Drug Therapy Longevity
Publication Types:	Lecture Webcast

NLM Classification:	WT 104
NLM ID:	101591637
CIT Live ID:	11603
Permanent link:	https://videocast.nih.gov/watch=11603

Related Videos...